Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Omics and AI advance biomarker discovery for liver disease

New technologies allow the noninvasive detection and staging of asymptomatic alcohol-associated liver disease; further refinement of this approach could transform clinical management and improve patient outcomes.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Conceptual model of the future of liver-disease management.


  1. GBD 2017 Cirrhosis Collaborators. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020).

    Article  Google Scholar 

  2. Singal, A. K. & Mathurin, P. J. Am. Med. Assoc. 326, 165–176 (2021).

    CAS  Article  Google Scholar 

  3. Niu, L. et al. Nat. Med. (2022).

    Article  PubMed  Google Scholar 

  4. Ahn, J. C. et al. Hepatology 73, 2546–2563 (2021).

    Article  Google Scholar 

  5. Yip, T. C. et al. Aliment. Pharmacol. Ther. 46, 447–456 (2017).

    CAS  Article  Google Scholar 

  6. Ioannou, G. N. et al. JAMA Netw. Open (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ahn, J. C. et al. Am. J. Gastroenterol. 117, 424–432 (2022).

    Article  Google Scholar 

  8. Forlano, R. et al. Clin. Gastroenterol. Hepatol. 18, 2081–2090 (2020).

    Article  Google Scholar 

  9. Morshid, A. et al. Radiol. Artif. Intell. (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Boehm, K. M. et al. Nat. Rev. Cancer 22, 114–126 (2022).

    CAS  Article  Google Scholar 

  11. Galior, K. et al. Bonekey Rep. 8, 268–273 (2018).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Vijay H. Shah.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wu, T., Cooper, S.A. & Shah, V.H. Omics and AI advance biomarker discovery for liver disease. Nat Med 28, 1131–1132 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing